Eli Lilly (LLY -1.8%) says it's received a positive opinion from the Committee for Medicinal...

|About: Eli Lilly and Company (LLY)|By:, SA News Editor

Eli Lilly (LLY -1.8%) says it's received a positive opinion from the Committee for Medicinal Products for Human Use in Europe recommending approval of Amyvid, a solution for injection as a diagnostic radiopharmaceutical in the brains of adult patients being evaluated for Alzheimer's Disease and other causes of cognitive impairment.